UCP1 and Hyperglycemia: Previous studies suggested the involvement of sympathetic activation in early metabolic dysfunction in triggering perivascular adipose tissue inflammation via increased uncoupling protein-1 expression and augmented hypoxia, which could allow unmitigated augmentation of inflammation driven by hyperglycemia as type 2 DM develops, at which time brainstem involvement would evoke further autonomic dysfunction (14–16).